65
Participants
Start Date
June 21, 2021
Primary Completion Date
June 12, 2023
Study Completion Date
June 12, 2023
ACU193
Intravenous ACU193
Placebo
Intravenous Placebo
Columbia University, New York
Abington Neurological Associates, Abington
AMC Research, Matthews
iResearch Atlanta, Decatur
Atlanta Center for Medical Research, Atlanta
Charter Research, Lady Lake
Progressive Medical Research, Port Orange
Combined Research Orlando Phase I-IV, Orlando
Velocity Clinical Research, Hallandale
Columbus Clinical Services, Miami
Santos Research Center, Tampa
Kerwin Medical Center, Dallas
Clinical Trials Network, Houston
Clinical Endpoints, Scottsdale
Hoag Hospital Newport Beach, Newport Beach
Orange County Research Institute, Anaheim
Advanced Memory Research Institute of NJ, Toms River
Lead Sponsor
National Institute on Aging (NIA)
NIH
Acumen Pharmaceuticals
INDUSTRY